SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V -- Ignore unavailable to you. Want to Upgrade?


To: Wisee who wrote (945)8/14/1998 12:24:00 PM
From: Paul S.  Read Replies (1) | Respond to of 1185
 
Wisee,

The upcoming completion of phase two clinical trials for RSD921 is expected in September. I would imagine that this will put a positive spin on the stock price.



To: Wisee who wrote (945)8/14/1998 10:41:00 PM
From: YABABY!  Read Replies (1) | Respond to of 1185
 
I can wait...your right. Not a bad return and it beats the GIC's. Got to pay attention and trade this baby!!!!

Regards,

Ya Baby!!!!